Found 10 matching trials
First-in-Human Single and Multiple Dose of GLPG2222 PHASE1 The purpose of this First-in-Human study is to evaluate the safety and tole...
Show More Location
SGS LSS Clinical Pharmacology Unit Antwerp
Learn More & Join Trial
A Study Looking at the Safety, Tolerability and Efficacy of the Combination of the Study Drugs GLPG2451 and GLPG2222 With or Without GLPG2737 in Patients With Cystic Fibrosis. PHASE1 This is a Phase Ib, multi-center, open-label, nonrandomized multiple cohort...
Show More Location
Study Site BEL004
Learn More & Join Trial
A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG2451 in Healthy Male Subjects PHASE1 The study is a Phase I, randomized, double-blind, placebo-controlled study ...
Show More Location
SGS LSS Clinical Pharmacology Unit Antwerp
Learn More & Join Trial
A Study to Evaluate GLPG2222 in Ivacaftor-treated Subjects With Cystic Fibrosis PHASE2 This clinical study is a phase IIa, multi-center, randomized, double-blind,...
Show More Location
The Prince Charles Hospital
Learn More & Join Trial
A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG2451 in Healthy Female Subjects PHASE1 The study is a First-in-Human, Phase I, randomized, double-blind, placebo-c...
Show More Location
SGS LSS Clinical Pharmacology Unit Antwerp
Learn More & Join Trial
A Study to Assess How Food Affects the Safety and Pharmacokinetics of Galicaftor and Navocaftor PHASE1 Cystic Fibrosis (CF) is a rare, life-threatening, genetic disease that affe...
Show More Location
Clinical Pharmacology of Miami /ID# 249531
Learn More & Join Trial
A Phase 2 Study of ABBV-3067 Alone and in Combination With ABBV-2222 PHASE2 This study will evaluate the safety, tolerability, and efficacy of ABBV-306...
Show More Location
University of Arkansas /ID# 212541
Learn More & Join Trial
A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG3067 in Healthy Subjects. PHASE1 The study is a First-in-Human, Phase I, randomized, double-blind, placebo-c...
Show More Location
SGS LSS Clinical Pharmacology Unit Antwerp
Learn More & Join Trial
A Study to Evaluate Multiple Doses of GLPG2222 in Adult Subjects With Cystic Fibrosis PHASE2 This is a Phase IIa, multi-center, randomized, double-blind, placebo-contro...
Show More Location
Child Health Research Unit at UAB
Learn More & Join Trial
Study to Evaluate Adverse Events and Change in Disease Activity With Oral Capsules of Galicaftor/Navocaftor/ABBV-119 or Galicaftor/Navocaftor/ABBV-576 Combination Therapies in Adult Participants With Cystic Fibrosis PHASE2 Cystic Fibrosis (CF) is a rare, life-threatening, genetic disease that affe...
Show More Location
Velocity Clinical Research /ID# 248675
Learn More & Join Trial